A comparison of medical induction and dilation and evacuation for second-trimester abortion

Study of efficacy of mifepristone as inducing agent for mid trimester medical termination of pregnancy in women with previous cesarean section

“…[12][13][14][15][16] For second trimester abortion (13-24 weeks of gestation), medical abortion with mifepristone followed by a prostaglandin analogue is an appropriate method and has been shown to be safe and effective, according to WHO and the RCOG. [17][18][19][20][21][22] It has been well proven that pretreatment with mifepristone 24-48 hours before prostaglandin administration increases the success rate, shortens the induction-to-abortion interval and reduces the amount of prostaglandins required in the second trimester in unscarred uteri. 23,24 In our series women with previous LSCS ,mifepristone 200 mg was given 36 hours prior to the misoprostol or oxytocin and found that none of the cases had incomplete abortion or rupture probably because we had ensured improvement in Bishop's score even by putting Foley's bulb before administration of prostaglandins.…”

Surgical Abortion in the Second Trimester

“…Autry and colleagues 17 retrospectively assessed complications with D&E and a variety of induction regimens in 297 women. The most common medication used for induction abortion was misoprostol.…”

Fetal Echocardiography and Prenatal Cardiovascular Interventions – An Update (2012)

“…Still, early diagnosis provides time for further testing, including chorionic villus sampling or amniocentesis for fetal karyotype, time to observe progression, time to consider the impact of the fetal pathology as well as choice for early pregnancy termination which poses a lower risk to the pregnant woman [74,75]. In contrast, the traditional mid trimester assessment results in little time to be certain the decisions made by 23 weeks are appropriate for the affected pregnancy and may miss a critical window of opportunity for intervention to change the natural history of disease that is evolving in utero in the first half of gestation.…”